{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:43:54Z","timestamp":1760730234664},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s10384-010-0887-9","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T15:29:24Z","timestamp":1297956564000},"page":"57-61","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Yukihiro","family":"Horie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Kitaichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshie","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"887_CR1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A. Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208\u2013214.","journal-title":"Pigment Cell Res"},{"key":"887_CR2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","volume":"18","author":"G. Laberge","year":"2005","unstructured":"Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res, 2005;18:300\u2013305.","journal-title":"Pigment Cell Res"},{"key":"887_CR3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJMe078017","volume":"356","author":"P.K. Gregersen","year":"2007","unstructured":"Gregersen PK. Modern genetics, ancient defenses, and potential therapies. N Engl J Med 2007;356:1263\u20131266.","journal-title":"N Engl J Med"},{"key":"887_CR4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","volume":"356","author":"Y. Jin","year":"2007","unstructured":"Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007;356:1216\u201325.","journal-title":"N Engl J Med"},{"key":"887_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10384-006-0383-4","volume":"51","author":"H. Goto","year":"2007","unstructured":"Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 2007;51:41\u201344.","journal-title":"Jpn J Ophthalmol"},{"key":"887_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1755-3768.2008.01282.x","volume":"87","author":"H. Kitamei","year":"2009","unstructured":"Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 2009;87:424\u2013428.","journal-title":"Acta Ophthalmol"},{"key":"887_CR7","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.4049\/jimmunol.165.12.7323","volume":"165","author":"K. Yamaki","year":"2000","unstructured":"Yamaki K, Gocho K, Hayakawa K, et al. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000;165:7323\u20137329.","journal-title":"J Immunol"},{"key":"887_CR8","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajo.2005.01.046","volume":"139","author":"M. Kitamura","year":"2005","unstructured":"Kitamura M, Takami K, Kitaichi N, et al. Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada\u2019s disease. Am J Ophthalmol 2005;139:1080\u20131085.","journal-title":"Am J Ophthalmol"},{"key":"887_CR9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"R.W. Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647\u2013652.","journal-title":"Am J Ophthalmol"},{"key":"887_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.exer.2004.09.010","volume":"80","author":"K. Yamaki","year":"2005","unstructured":"Yamaki K, Takiyama N, Itho N, et al. Experimentally induced Vogt-Koyanagi-Harada disease in two Akita dogs. Exp Eye Res 2005;80:273\u2013280.","journal-title":"Exp Eye Res"},{"key":"887_CR11","first-page":"1601","volume":"12","author":"Y. Horie","year":"2006","unstructured":"Horie Y, Takemoto Y, Miyazaki A, et al. Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 2006;12:1601\u20131605.","journal-title":"Mol Vis"},{"key":"887_CR12","first-page":"3890","volume":"35","author":"S.M. Islam","year":"1994","unstructured":"Islam SM, Numaga J, Fujino Y, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994; 35:3890\u20133896.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"887_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1959.49","volume":"32","author":"A.B. Lerner","year":"1959","unstructured":"Lerner AB. Vitiligo. J Invest Dermatol 1959;32:285\u2013310.","journal-title":"J Invest Dermatol"},{"key":"887_CR14","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","volume":"177","author":"T. Lambe","year":"2006","unstructured":"Lambe T, Leung JC, Bouriez-Jones T, et al. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J Immunol 2006;177:3055\u20133062.","journal-title":"J Immunol"},{"key":"887_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K. Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003;16:90\u2013100.","journal-title":"Pigment Cell Res"},{"key":"887_CR16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","volume":"22","author":"P.K. Das","year":"2001","unstructured":"Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, et al. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol 2001;22:130\u2013136.","journal-title":"Trends Immunol"},{"key":"887_CR17","first-page":"1219","volume":"148","author":"I.C. Poole Le","year":"1996","unstructured":"Le Poole IC, van den Wijngaard RM, Westerhof W, et al. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996;148:1219\u20131228.","journal-title":"Am J Pathol"},{"key":"887_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","volume":"117","author":"B. Palermo","year":"2001","unstructured":"Palermo B, Campanelli R, Garbelli S, et al. Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001;117:326\u2013332.","journal-title":"J Invest Dermatol"},{"key":"887_CR19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0749.2003.00038.x","volume":"16","author":"A. Wankowicz-Kalinska","year":"2003","unstructured":"Wankowicz-Kalinska A, Le Poole C, van den Wijngaard R, et al. Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin? Pigment Cell Res 2003;16:254\u2013260.","journal-title":"Pigment Cell Res"},{"key":"887_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jmicro\/dfm036","volume":"57","author":"F. Prignano","year":"2008","unstructured":"Prignano F, Betts CM, Lotti T. Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin? J Electron Microsc (Tokyo) 2008;57:25\u201331.","journal-title":"J Electron Microsc (Tokyo)"},{"key":"887_CR21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"J.P. Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 2001;411:599\u2013603.","journal-title":"Nature"},{"key":"887_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","volume":"4","author":"L.D. Church","year":"2008","unstructured":"Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008;4:34\u201342.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"887_CR23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1074-7613(02)00480-6","volume":"17","author":"M.T. Spiotto","year":"2002","unstructured":"Spiotto MT, Yu P, Rowley DA, et al. Increasing tumor antigen expression overcomes \u201cignorance\u201c to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002;17:737\u2013747.","journal-title":"Immunity"},{"key":"887_CR24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","volume":"198","author":"W.W. Overwijk","year":"2003","unstructured":"Overwijk WW, Theoret MR, Finkelstein SE, et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 2003;198:569\u2013580.","journal-title":"J Exp Med"},{"key":"887_CR25","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1200\/JCO.2001.19.15.3477","volume":"19","author":"G.Q. Phan","year":"2001","unstructured":"Phan GQ, Attia P, Steinberg SM, et al. Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. J Clin Oncol 2001;19:3477\u20133482.","journal-title":"J Clin Oncol"},{"key":"887_CR26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0749.2007.00393.x","volume":"20","author":"A. Taieb","year":"2007","unstructured":"Taieb A. NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders. Pigment Cell Res 2007;20:260\u2013262.","journal-title":"Pigment Cell Res"},{"key":"887_CR27","first-page":"1299","volume":"80","author":"R. Wijngaard van den","year":"2000","unstructured":"van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000;80:1299\u20131309.","journal-title":"Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest"},{"key":"887_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10792-006-9016-7","volume":"27","author":"N. Kitaichi","year":"2007","unstructured":"Kitaichi N, Matoba H, Ohno S. The positive role of lumbar puncture in the diagnosis of Vogt-Koyanagi-Harada disease: lymphocyte subsets in the aqueous humor and cerebrospinal fluid. Int Ophthalmol 2007;27:97\u2013103.","journal-title":"Int Ophthalmol"},{"key":"887_CR29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","volume":"39","author":"R.S. Moorthy","year":"1995","unstructured":"Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265\u2013292.","journal-title":"Surv Ophthalmol"},{"key":"887_CR30","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00417-008-0869-5","volume":"246","author":"N. Kitaichi","year":"2008","unstructured":"Kitaichi N, Horie Y, Ohno S. Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 2008;246:1641\u20131642.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"887_CR31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0002-9394(77)90142-8","volume":"83","author":"S. Ohno","year":"1977","unstructured":"Ohno S, Char DH, Kimura SJ, et al. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1977;83:735\u2013740.","journal-title":"Am J Ophthalmol"},{"key":"887_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200604620-00011","volume":"46","author":"C.M. Andreoli","year":"2006","unstructured":"Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2006;46:111\u2013122.","journal-title":"Int Ophthalmol Clin"},{"key":"887_CR33","first-page":"2334","volume":"13","author":"Y. Horie","year":"2007","unstructured":"Horie Y, Kitaichi N, Takemoto Y, et al. Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease. Mol Vis 2007;13:2334\u20132338.","journal-title":"Mol Vis"},{"key":"887_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2008.01.004","volume":"127","author":"L. Du","year":"2008","unstructured":"Du L, Yang P, Hou S, et al. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol 2008;127: 43\u201348.","journal-title":"Clin Immunol"},{"key":"887_CR35","first-page":"2597","volume":"14","author":"S. Hou","year":"2008","unstructured":"Hou S, Yang P, Du L, et al. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. Mol Vis 2008;14:2597\u20132603.","journal-title":"Mol Vis"},{"key":"887_CR36","first-page":"386","volume":"15","author":"Q. Meng","year":"2009","unstructured":"Meng Q, Liu X, Yang P, et al. PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Mol Vis 2009;15:386\u2013392.","journal-title":"Mol Vis"},{"key":"887_CR37","first-page":"1537","volume":"15","author":"S. Hou","year":"2009","unstructured":"Hou S, Yang P, Xie L, et al. Monocyte chemoattractant protein (MCP)-1 -2518 A\/G SNP in Chinese Han patients with VKH syndrome. Mol Vis 2009;15:1537\u20131541.","journal-title":"Mol Vis"},{"key":"887_CR38","first-page":"1115","volume":"15","author":"Y. Horie","year":"2009","unstructured":"Horie Y, Kitaichi N, Katsuyama Y, et al. Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 2009;15:1115\u20131119.","journal-title":"Mol Vis"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-010-0887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-010-0887-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-010-0887-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T16:30:20Z","timestamp":1560011420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-010-0887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s10384-010-0887-9","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}